Others

Dishman Carbogen Amcis Ltd - DISCLOSURE PURSUANT TO REGULATION 30 OF SEBI (LODR) REGULATIONS, 2015: COMPANYS NARODA UNIT RECEIVED ESTABLISHMENT INSPECTION REPORT (EIR) FROM US FDA

| Updated on April 30, 2019 Published on April 30, 2019

With reference to the captioned subject, we would like to inform that the Companys Naroda facility was successfully inspected by the US FDA in February, 2019, which was intimated to the stock exchange on 15th February, 2019. We are pleased to share that we have received the Establishment Inspection Report (EIR) from the US FDA for this facility on yesterday.

Thus, the Companys facilities in Bavla and Naroda in India, multiple facilities in Switzerland and the Netherlands continue to be approved by the US FDA.

Pdf Link: Dishman Carbogen Amcis Ltd - DISCLOSURE PURSUANT TO REGULATION 30 OF SEBI (LODR) REGULATIONS, 2015: COMPANYS NARODA UNIT RECEIVED ESTABLISHMENT INSPECTION REPORT (EIR) FROM US FDA

Source : BSE - www.bseindia.com

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on April 30, 2019
This article is closed for comments.
Please Email the Editor